Showing results (91-100 of 105) with videos related to
Sort By:
Pageof 11
American Journal of Hematology|May 8, 2023
Kinetics of cellular and humoral immunogenicity and effectiveness of SARS-CoV-2 booster vaccination in hematologic neoplasmsMoraima Jiménez, Candela Fernández-Naval, Víctor Navarro, et al.Cancer Medicine|April 20, 2026
Progression-Free Survival 2 as a Potential Surrogate for Overall Survival in Glioblastoma: Insights From a Spanish Multicentric CohortJesús Yaringaño, Oriol Mirallas, Víctor Navarro, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2023
Recent Bendamustine Treatment Before Apheresis Has a Negative Impact on Outcomes in Patients With Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell TherapyGloria Iacoboni, Víctor Navarro, Ana África Martín-López, et al.Hemasphere|July 1, 2024
Efficacy and safety of bendamustine-containing bridging therapy in R/R LBCL patients receiving CD19 CAR T-cellsGloria Iacoboni, Mario A Sánchez-Salinas, Kai Rejeski, et al.BMC Cancer|December 1, 2018
Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC studyAna Fernández, Mercedes Salgado, Adelaida García, et al.Leukemia|April 1, 2025
Site-specific analysis of extranodal involvement in large B-cell lymphoma reveals distinct efficacy with chimeric antigen receptor T-cell therapyGloria Iacoboni, Kai Rejeski, Víctor Navarro, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2025
Phase II study of perioperative Avelumab plus chemotherapy for patients with resectable gastric cancer or gastroesophageal junction cancer - the MONEO StudyMaria Alsina, Guillermo Villacampa, Carlos de Andrea, et al.Journal of Hematology & Oncology|October 29, 2024
Development and validation of the post-CAR prognostic index for large B-cell lymphoma patients after CAR-T progression in third or later line treatmentGloria Iacoboni, Víctor Navarro, Pierre Sesques, et al.Hemasphere|May 22, 2024
Treatment outcomes in patients with large B-cell lymphoma after progression to chimeric antigen receptor T-cell therapyGloria Iacoboni, Josu Iraola-Truchuelo, Maeve O'Reilly, et al.Cancers|October 16, 2025
Safety of Post-Transplant Cyclophosphamide-Based Prophylaxis in AML Patients with Pre-Existing Cardiac Morbidity Undergoing Allogeneic Hematopoietic Cell TransplantationArnau Torrent-Rodríguez, Enric Cascos, Víctor Navarro Garcés, et al.Pageof 11